Trials / Conditions / Myelogenous Leukemia, Chronic, Chronic Phase
Myelogenous Leukemia, Chronic, Chronic Phase
3 registered clinical trials studyying Myelogenous Leukemia, Chronic, Chronic Phase.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial NCT01887561 | Kanto CML Study Group | Phase 2 |
| Unknown | Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan NCT01464411 | Kanto CML Study Group | — |
| Terminated | Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C NCT00038649 | M.D. Anderson Cancer Center | Phase 2 |